Breaking News Instant updates and real-time market news.

PEP

PepsiCo

$112.89

5.11 (4.74%)

, TSLA

Tesla

$322.34

3.82 (1.20%)

16:28
07/10/18
07/10
16:28
07/10/18
16:28

Fly Intel: Wall Street's top stories for Tuesday

Stocks on Wall Street had a mostly quiet, but positive, day of trading as investors continue to wait on the real kick off of the earnings season. In a bit of a preview, and an encouraging one, PepsiCo (PEP) reported earnings that topped expectations and backed its full-year outlook, sending shares of the snack and beverage giant higher. ECONOMIC EVENTS: In the U.S., the job openings and labor turnover - or JOLTS - report showed job openings dropped 202,000 to 6.64M in May. However, that was after climbing 207,000 to a record high of 6.84M in April. COMPANY NEWS: Shares of PepsiCo gained nearly 5% after the company's core earnings were powered by Frito-Lay North America operating profit growth of 5%, which helped offset the fact that North America Beverages operating profit decreased 16%. Pepsi CEO Indra Nooyi, who affirmed the company's full-year outlook, said the "majority" of the company's businesses performed very well in Q2... Tesla (TSLA) advanced 1% after Bloomberg reported that the electric car maker will sign a memorandum of understanding to build a plant in China capable of producing 500,000 vehicle per year... Meanwhile, the U.S. Federal Trade Commission filed a lawsuit against the Tronox (TROX), claiming that its pending acquisition of Cristal's titanium dioxide business would violate antitrust laws. In response, Tronox said it is ready to demonstrate the pro-competitive merits of the transaction. MAJOR MOVERS: Among the noteworthy gainers was Stitch Fix (SFIX), which rose 6% after launching Stitch Fix Kids and having KeyBanc analyst Edward Yruma start covering the stock with an Overweight rating and a $38 price target. Also higher was Casa Systems (CASA), which gained 8.5% after Morgan Stanley analyst Meta Marshall upgraded the stock to Overweight. Among the notable losers was Nordstrom (JWN), which fell 3% after it reaffirmed its fiscal 2018 guidance and provided a net sales growth outlook for 2017-2022 as part of its first analyst day meeting. Also lower was AutoNation (AN), which slipped 4% after Morgan Stanley analyst Armintas Sinkevicius double downgraded the stock to Underweight from Overweight. INDEXES: The Dow rose 143.07, or 0.58%, to 24,919.66, the Nasdaq gained 3.00, or 0.04%, to 7,759.20, and the S&P 500 advanced 9.67, or 0.35%, to 2,793.84.

PEP

PepsiCo

$112.89

5.11 (4.74%)

TSLA

Tesla

$322.34

3.82 (1.20%)

TROX

Tronox

$20.47

0.01 (0.05%)

SFIX

Stitch Fix

$32.97

1.86 (5.98%)

CASA

Casa Systems

$17.79

1.41 (8.61%)

JWN

Nordstrom

$52.09

-1.45 (-2.71%)

AN

AutoNation

$48.36

-2.13 (-4.22%)

  • 10

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 08

    Aug

  • 08

    Aug

PEP PepsiCo
$112.89

5.11 (4.74%)

07/09/18
RBCM
07/09/18
NO CHANGE
Target $111
RBCM
Sector Perform
PepsiCo to remain constrained by troubled Beverage business, says RBC Capital
RBC Capital analyst Nik Modi previews Q2 results for PepsiCo, saying he expects the trends of troubled North America Beverage business and poor earnings quality that have been on display over the past few quarters to persist. Modi further warns that FX and cost increases will worsen in this quarter, while the operating environment becomes more uncertain because of the threat of trade wars. The analyst keeps his Sector Perform rating and $111 price target on PepsiCo.
07/06/18
WELS
07/06/18
NO CHANGE
Target $107
WELS
Market Perform
Wells Fargo cautious on PepsiCo fundamentals into Q2 results
Wells Fargo analyst Bonnie Herzog is cautious on PepsiCo's fundamentals ahead of the company's Q2 earnings results on July 10. The analyst reduced her fiscal 2018 and 2019 estimates to reflect continued weakness in North American beverages, lower sales in Latin America following the May trucker strike in Brazil and incremental currency headwinds. However, despite these continued pressures, the market could react favorably to PepsiCo management providing more details on their ultimate plans for the Beverage business, Herzog tells investors in a pre-earnings research note titled "PEP: We're Not Feeling So Bubly About PEP's Q2 Fundamentals." The analyst keeps a Market Perform rating on PepsiCo with a $107 price target.
07/03/18
07/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL), American Airlines (AAL), and Delta Airlines (DAL) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying in a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market. 2. Belmond (BEL) downgraded to Underweight from Overweight at Barclays with analyst Felicia Hendrix citing an analysis of the company's progress on its growth targets announced back in June 2016. 3. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank with analyst Jonathan Arnold saying The Federal Energy Regulatory Commission order raised new questions over New Jersey zero-emission credits. 4. PepsiCo (PEP) downgraded to Hold from Buy at Deutsche Bank with analyst Stephen Powers viewing the current valuation as a "bit bubbly." 5. Watsco (WSO), Fastenal (FAST), and Grainger (GWW) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he thinks the cycle and individual company results could remain solid for quarters or years to come, but he believes the cycle is in its later stages, thereby elevating risks to gross margins, rising labor costs, and earnings deceleration in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/03/18
DBAB
07/03/18
DOWNGRADE
Target $116
DBAB
Hold
PepsiCo downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Stephen Powers downgraded PepsiCo to Hold with an unchanged price target of $116. The stock closed yesterday up 66c to $109.53. The analyst views the current valuation as a "bit bubbly." With at least 36 months of elevated investment, the stock's current risk/reward is fairly balanced, Powers tells investors in a research note.
TSLA Tesla
$322.34

3.82 (1.20%)

07/10/18
KEYB
07/10/18
NO CHANGE
KEYB
Sector Weight
Tesla production potential a chance to talk bull case, says KeyBanc
After Bloomberg reported that Tesla is expected to to sign a memorandum of understanding in Shanghai to build a plant in China capable of producing 500,000 vehicle per year, KeyBanc analyst Brad Erickson told investors in a research note that "this is just the kind of announcement and scenario contemplated" in his positive near-term bias, whereby he thinks investors would attribute some incremental value associated with the incremental production well ahead of revenue. Erickson believes the company's formal messaging of China production will come before the company showing more meaningful steps toward Model 3 profitability, as a China factory will likely require an incremental capital raise. The analyst, who has a Sector Weight rating on Tesla shares, sees Tesla delivering about 426,000 vehicles at an average selling price of about $57,600 in 2020, while doing an additional $4.3B in battery revenue at an operating margin of 8%.
07/03/18
GSCO
07/03/18
NO CHANGE
GSCO
Sell
Tesla demand data point a concern, says Goldman Sachs
Goldman Sachs analyst David Tamberrino notes that while Tesla did achieve its 5k/week production target for the Model 3, the company's Model 3 deliveries did miss the analyst's bearish estimates. Further, he sees the incremental color on Model 3 net reservations where the company showed its first declining data point as incrementally negative. Tamberrino reiterates a Sell rating on the shares.
07/03/18
NOMU
07/03/18
NO CHANGE
Target $450
NOMU
Buy
Tesla reestablished some credibility yesterday, says Nomura Instinet
Tesla yesterday confirmed that it hit its production target of 5,000 Model 3's in the final week of the quarter, an important milestone that reestablishes some credibility and positions the company for profitability in the second half of the year, Nomura Instinet analyst Romit Shah tells investors in a research note. The analyst, however, continues to expect Tesla shares to be volatile near term. He sees the current weakness as an opportunity to further accumulate shares and keeps a Buy rating on the name with a $450 price target. Tesla closed yesterday down $7.88 to $335.07.
07/03/18
JPMS
07/03/18
NO CHANGE
Target $180
JPMS
Overweight
Tesla announced 'another significant' delivery miss, says JPMorgan
Tesla announced yesterday that Q2 deliveries tracked 40,740 vehicles, another "significant miss" versus the consensus of 48,874 and JPMorgan's estimate of 56,500, analyst Ryan Brinkman tells investors in a research note. While deliveries disappointed again in Q2, Tesla appears to have better met expectations relative to production, which tracked much higher than sales at 53,339 vehicles, Brinkman adds. The analyst believes the delivery miss highlights ongoing execution risk and suggests "softer" earnings. He keeps an Underweight rating on Tesla shares with a $180 price target. Brinkman expects a negative reaction in Tesla shares.
TROX Tronox
$20.47

0.01 (0.05%)

02/07/18
02/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc. (HPQ) was initiated with a Neutral at Goldman Sachs, while Cisco (CSCO) was initiated with a Buy. 2. Tronox (TROX) initiated with an Outperform at Wells Fargo. 3. Data I/O (DAIO) initiated with a Buy at RF Lafferty. 4. SailPoint Technologies (SAIL) initiated with a Buy at Needham. 5. Aimmune (AIMT) initiated with an Outperform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/18
WELS
02/07/18
INITIATION
Target $28
WELS
Outperform
Tronox initiated with an Outperform at Wells Fargo
Wells Fargo analyst Frank Mitsch started Tronox with an Outperform rating and $28 price target. The analyst has a positive view on the company's acquisition of Cristal and a favorable near-term/sustainable mid-term outlook of TiO2.
03/27/18
BMOC
03/27/18
INITIATION
Target $24
BMOC
Outperform
Tronox initiated with an Outperform at BMO Capital
BMO Capital analyst John McNulty started Tronox with an Outperform rating and $24 price target.
01/30/18
01/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altair (ALTR) initiated with a Buy at Berenberg. 2. Chemours (CC), Tronox (TROX) and Venator Materials (VNTR) initiated with an Equal Weight at Morgan Stanley. 3. Oclaro (OCLR), Lumentum (LITE) and Acacia Communications (ACIA) initiated with a Buy at Loop Capital. 4. Rocket Pharmaceuticals (RCKT) initiated with an Outperform at Evercore ISI. 5. U.S. Steel (X) initiated with a Sell at Vertical Group. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
SFIX Stitch Fix
$32.97

1.86 (5.98%)

03/19/18
BUCK
03/19/18
INITIATION
BUCK
Neutral
Stitch Fix initiated with a Neutral at Buckingham
03/13/18
JPMS
03/13/18
NO CHANGE
JPMS
Stitch Fix lock-up tomorrow could bring near-term weakness, says JPMorgan
JPMorgan analyst Doug Anmuth says active client growth modestly accelerated to 31% year-over-year, leading to Stitch Fix's fourth straight quarter of 25% year-over-year revenue growth. The analyst, however, keeps a Neutral rating on the shares with a $26 price target following last night's Q4 results. He expects advertising spend and headcount growth will continue to weigh on margins. Further, Anmuth estimates 31M shares will be released from lock-up tomorrow, March 14, before the market open, versus the current 9M share float. This could create near-term weakness in the shares, Anmuth tells investors in a research note.
06/22/18
WBLR
06/22/18
NO CHANGE
WBLR
William Blair does not see tax ruling impacting e-commerce companies
William Blair analyst Ryan Domyancic does not believe yesterday's Supreme Court ruling on state sales tax will have an adverse impact on the e-commerce companies he covers: Amazon.com (AMZN), Wayfair (W), and Stitch Fix (SFIX). He notes that his findings indicate that Amazon's price discount is not driven by a lack of sales tax. Further, Stitch Fix's primary value proposition is customized style rather than deep discounts, Domyancic tells investors in a research note. On Wayfair, the analyst thinks the collection of sales tax in incremental states has not affected its growth over the past several years.
07/09/18
KEYB
07/09/18
INITIATION
Target $38
KEYB
Overweight
Stitch Fix initiated with an Overweight at KeyBanc
KeyBanc started Stitch Fix with an Overweight rating and $38 price target.
CASA Casa Systems
$17.79

1.41 (8.61%)

07/10/18
07/10/18
UPGRADE
Target $23

Overweight
Casa Systems upgraded to Overweight after pullback at Morgan Stanley
As previously reported, Morgan Stanley analyst Meta Marshall upgraded Casa Systems to Overweight from Equal Weight, stating that the sharp pullback in the stock over the past couple of months, which she attributes to a secondary offering prior to lockup expiration in April and full year guidance not being raised despite a 6% revenue beat with its Q1 report in May, is providing too much of a discount for its core cable business and expansion opportunities. Marshall maintains her $23 price target on Casa Systems shares.
07/10/18
MSCO
07/10/18
UPGRADE
MSCO
Overweight
Casa Systems upgraded to Overweight from Equal Weight at Morgan Stanley
03/07/18
STFL
03/07/18
NO CHANGE
Target $27
STFL
Buy
Casa Systems price target raised to $27 after first public report at Stifel
Stifel analyst Patrick Newton said Casa Systems' revenue topped his expectations in the company's first report since coming public and its pro forma EPS of $1.07 was "well above" his 34c forecast, driven by higher than expected gross margin, a lower tax rate and lower than expected shares outstanding. DOCSIS 3.1 trends are accelerating, management continues to see a ramp of DAA in the second half and wireless momentum is building, said Newton, who raised his price target on Casa shares to $27 from $23 and keeps a Buy rating on the stock.
01/10/18
MACQ
01/10/18
INITIATION
Target $24
MACQ
Outperform
Casa Systems initiated with an Outperform at Macquarie
Macquarie analyst Sarah Hindlian initiated Casa Systems with an Outperform and $24 price target. The analyst expects Casa to continue to gain share it its core $2B CY17 Converged Cable Access Platform market, benefiting from software defined solutions, expansion beyond its strong core position to adjacent areas of network transformation solutions.
JWN Nordstrom
$52.09

-1.45 (-2.71%)

07/09/18
KEYB
07/09/18
DOWNGRADE
KEYB
Sector Weight
Urban Outfitters downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Edward Yruma downgraded Urban Outfitters to Sector Weight. The analyst downgraded shares of Nordstrom (JWN).
07/05/18
DBAB
07/05/18
NO CHANGE
DBAB
Buy
Nordstrom to detail EBIT expansion at investor day, says Deutsche Bank
Deutsche Bank analyst Paul Trussell believes Nordstrom at the company's first investor day on July 10 will lay out the path back to EBIT expansion with a further moderation in spending growth, and set longer-term comp and profitability targets. The analyst says he's heading into the event with optimism despite "much investor skepticism" that persists. He also expects Nordstrom's capital return story to accelerate as spending is projected to decelerate through fiscal 2022, combined with a likely new share buyback program. Trussell keeps a Buy rating on Nordstrom shares.
07/10/18
07/10/18
DOWNGRADE

Sector Weight
Nordstrom downgraded to Sector Weight on risk/reward prospects at KeyBanc
As previously reported, KeyBanc analyst Edward Yruma downgraded Nordstrom to Sector Weight from Overweight to reflect a more balanced near-term risk reward prospects. The analyst remains impressed by the company's openness to reinventing itself, but initiatives like pop-ups, product exclusives, and remodels have been unable to counter the natural traffic migration to e-commerce at the full-line stores. While capex may fall as previously indicated, more dramatic changes may be required to improve performance, he adds.
07/09/18
KEYB
07/09/18
DOWNGRADE
KEYB
Sector Weight
Nordstrom downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Edward Yruma downgraded Nordstrom to Sector Weight.
AN AutoNation
$48.36

-2.13 (-4.22%)

03/14/18
MSCO
03/14/18
NO CHANGE
MSCO
Morgan Stanley raises U.S. auto sales forecasts through 2021
Morgan Stanley analyst Adam Jonas raised his U.S. seasonally adjusted annual rate, or SAAR, forecast for automakers by an average of 850,000 units from 2018 through 2021, which represents slightly more than a 5% increase from his prior forecast. However, his average U.S. SAAR forecast is still well below last year's 17.3M units and 8% under the cyclical high of 17.6M units in 2016. Jonas points to U.S. tax reform and "relatively stable" recent trends in auto sales and credit as reasons for the hike, noting that while infrastructure action from the federal government could be a material positive, it is not explicitly in his new forecast. Adding that the higher view has a net positive impact on estimates and price targets for exposed auto Original Equipment Manufacturers, or OEMs, and suppliers, Jonas raised his price targets on General Motors (GM), Asbury Automotive (ABG), AutoNation (AN), Group 1 Automotive (GPI), Lithia Motors (LAD), Penske Automotive (PAH), Sonic Automotive (SAH) and Ford (F). He also double upgraded Ford, to Overweight from Underweight, this morning.
04/16/18
GUGG
04/16/18
INITIATION
GUGG
Neutral
AutoNation initiated with a Neutral at Guggenheim
Guggenheim analyst Ali Faghri initiated AutoNation with a Neutral rating.
07/10/18
MSCO
07/10/18
DOWNGRADE
MSCO
Underweight
AutoNation, Sonic Automotive double downgraded to Underweight at Morgan Stanley
Morgan Stanley analyst Armintas Sinkevicius double downgraded AutoNation (AN) and Sonic Automotive (SAH), each to Underweight from Overweight, as he took over coverage of the auto dealer stocks at the firm. Longer term, he is constructive on dealers, citing a belief that tech disruption could accelerate consolidation and set up a transition toward "megafleet managers." However, given that the market is over 9 years into the auto cycle, he sees limited potential for a re-rating of the multiples of auto dealer's stocks, Sinkevicius tells investors. In supporting his view, he notes that both stocks trade at a premium to the rest of the group. Sinkevicius also retains an Underweight rating on Group 1 Automotive (GPI) given its premium valuation.
12/04/17
MOFT
12/04/17
INITIATION
MOFT
Neutral
AutoNation initiated with a Neutral at MoffettNathanson

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

A

Agilent

$64.47

-1.28 (-1.95%)

, AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
American Society of Human Genetics to hold a conference »

ASHG Conference 2018 will…

A

Agilent

$64.47

-1.28 (-1.95%)

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

BMRN

BioMarin

$103.31

-0.52 (-0.50%)

BIO

Bio-Rad

$280.96

-3.23 (-1.14%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

ILMN

Illumina

$313.31

-7.98 (-2.48%)

FLDM

Fluidigm

$7.49

-0.45 (-5.67%)

HZNP

Horizon Pharma

$19.07

-0.01 (-0.05%)

NVTA

Invitae

$12.86

-0.23 (-1.76%)

NSTG

NanoString

$15.18

-0.41 (-2.63%)

QGEN

Qiagen

$35.91

0.455 (1.28%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

RTRX

Retrophin

$25.34

0.24 (0.96%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ARQL

ArQule

$4.33

-0.38 (-8.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 27

    Nov

  • 28

    Nov

  • 24

    Dec

  • 18

    Feb

  • 03

    Mar

CLBR

Caliburn International

$0.00

(0.00%)

18:27
10/19/18
10/19
18:27
10/19/18
18:27
Syndicate
Caliburn International files registration statement for proposed IPO »

Caliburn International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

18:10
10/19/18
10/19
18:10
10/19/18
18:10
General news
Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$99.62

2.61 (2.69%)

18:02
10/19/18
10/19
18:02
10/19/18
18:02
Hot Stocks
Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe »

Celanese announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

REGN

Regeneron

$389.94

-5.45 (-1.38%)

, SNY

Sanofi

$44.57

0.12 (0.27%)

17:57
10/19/18
10/19
17:57
10/19/18
17:57
Hot Stocks
Regeneron, Sanofi: FDA approves asthma indication for Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$389.94

-5.45 (-1.38%)

SNY

Sanofi

$44.57

0.12 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

, XLU

Utilities SPDR

$54.57

0.82 (1.53%)

17:55
10/19/18
10/19
17:55
10/19/18
17:55
General news
Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound »

S&P500 SECTORS: …

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

IYR

DJ US Real Estate Index Fund

$77.83

0.63 (0.82%)

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

XLF

Financial Select Sector

$26.66

0.08 (0.30%)

XLV

Health Care Select Sector SPDR

$91.48

-0.93 (-1.01%)

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

XLI

Industrial Select Sector SPDR

$73.17

-0.31 (-0.42%)

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

SLV

iShares Silver Trust

$13.74

0.05 (0.37%)

USO

United States Oil Fund

$14.72

0.155 (1.06%)

UNG

United States Natural Gas Fund

$26.81

0.19 (0.71%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.90

0.04 (0.05%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.69

-0.15 (-0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$113.73

-0.24 (-0.21%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.12

-0.12 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$82.95

-0.035 (-0.04%)

IWD

iShares Russell 1000 Value

$122.17

0.08 (0.07%)

IWF

iShares Russell 1000 Growth

$145.19

-0.5 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSW

International Seaways

$21.51

0.41 (1.94%)

17:53
10/19/18
10/19
17:53
10/19/18
17:53
Syndicate
Breaking Syndicate news story on International Seaways »

International Seaways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$15.49

0.08 (0.52%)

17:48
10/19/18
10/19
17:48
10/19/18
17:48
Hot Stocks
Monmouth Real Estate acquires industrial building in New Jersey for $85.25M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:38
10/19/18
10/19
17:38
10/19/18
17:38
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:36
10/19/18
10/19
17:36
10/19/18
17:36
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

, LMT

Lockheed Martin

$328.22

0.21 (0.06%)

17:33
10/19/18
10/19
17:33
10/19/18
17:33
Periodicals
Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports »

President Donald Trump…

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

LMT

Lockheed Martin

$328.22

0.21 (0.06%)

BA

Boeing

$356.28

-3 (-0.84%)

GD

General Dynamics

$190.43

-0.76 (-0.40%)

BAESY

BAE Systems

$0.00

(0.00%)

HON

Honeywell

$153.49

-1.73 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

ISR

IsoRay

$0.50

0.0191 (3.98%)

17:25
10/19/18
10/19
17:25
10/19/18
17:25
Syndicate
Breaking Syndicate news story on IsoRay »

IsoRay files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHS

Neuberger Berman High Yield Strategies Fd

$10.55

-0.015 (-0.14%)

17:06
10/19/18
10/19
17:06
10/19/18
17:06
Hot Stocks
Breaking Hot Stocks news story on Neuberger Berman High Yield Strategies Fd »

Saba Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOC

Biocept

$2.27

-0.04 (-1.73%)

17:04
10/19/18
10/19
17:04
10/19/18
17:04
Syndicate
Breaking Syndicate news story on Biocept »

Biocept files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$726.10

-4.09 (-0.56%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Hot Stocks
AutoZone founder Hyde will not stand for board re-election »

AutoZone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SACH

Sachem Capital

$4.33

0.02 (0.46%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Syndicate
Breaking Syndicate news story on Sachem Capital »

Sachem Capital files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

16:53
10/19/18
10/19
16:53
10/19/18
16:53
Conference/Events
Mirati Therapeutics to hold a conference call »

Dr. Charles Baum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SPNE

SeaSpine

$16.58

-0.54 (-3.15%)

16:47
10/19/18
10/19
16:47
10/19/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SeaSpine »

First Light Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

16:46
10/19/18
10/19
16:46
10/19/18
16:46
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

16:40
10/19/18
10/19
16:40
10/19/18
16:40
General news
Breaking General news story on MSCI Italy Index, SPDR S&P 500 ETF Trust, S&P 500 »

Moody's cuts Italy…

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$2.93

-0.02 (-0.68%)

16:39
10/19/18
10/19
16:39
10/19/18
16:39
Hot Stocks
Breaking Hot Stocks news story on Astrotech »

Winn Interests reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$15.43

-1.075 (-6.52%)

16:38
10/19/18
10/19
16:38
10/19/18
16:38
Conference/Events
CytomX Therapeutics to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ICLK

iClick Interactive Asia

$3.41

(0.00%)

16:36
10/19/18
10/19
16:36
10/19/18
16:36
Hot Stocks
Breaking Hot Stocks news story on iClick Interactive Asia »

LIM Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.